SERA PROGNOSTICS, INC. Operating Lease, Payments
SERA PROGNOSTICS, INC. (SERA) reported Operating Lease, Payments of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-08-12
- SERA PROGNOSTICS, INC. operating lease, payments for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- SERA PROGNOSTICS, INC. operating lease, payments for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- SERA PROGNOSTICS, INC. operating lease, payments for the quarter ending 2025-12-31 was $167.00K, a 3.73% increase year-over-year.
- SERA PROGNOSTICS, INC. operating lease, payments for the quarter ending 2025-09-30 was $166.00K, a 2.47% increase year-over-year.
- SERA PROGNOSTICS, INC. operating lease, payments for fiscal 2025 was $666.00K, a 3.10% increase from fiscal 2024.
- SERA PROGNOSTICS, INC. operating lease, payments for fiscal 2024 was $646.00K, a 2.87% increase from fiscal 2023.
- SERA PROGNOSTICS, INC. operating lease, payments for fiscal 2023 was $628.00K, a 3.12% increase from fiscal 2022.
- SERA PROGNOSTICS, INC. operating lease, payments for fiscal 2022 was $609.00K.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-12 | $0.00 10-Q · filed 2026-08-12 | $167.00K derived: sum of 3 quarters · filed 2026-08-12 | $333.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-06 | $167.00K derived: sum of 2 quarters · filed 2026-05-06 | $333.00K derived: sum of 3 quarters · filed 2026-05-06 | $499.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $167.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $333.00K derived: sum of 2 quarters · filed 2026-03-18 | $499.00K derived: sum of 3 quarters · filed 2026-08-12 | $666.00K 10-K · filed 2026-03-18 |
| 2025-09-30 | $166.00K 10-Q · filed 2025-11-13 | $332.00K derived: sum of 2 quarters · filed 2026-08-12 | $499.00K 10-Q · filed 2025-11-13 | $659.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $166.00K 10-Q · filed 2026-08-12 | $333.00K 10-Q · filed 2026-08-12 | $493.00K derived: sum of 3 quarters · filed 2026-08-12 | $655.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $166.00K 10-Q · filed 2026-05-06 | $327.00K derived: sum of 2 quarters · filed 2026-05-06 | $489.00K derived: sum of 3 quarters · filed 2026-05-06 | $651.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $161.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $323.00K derived: sum of 2 quarters · filed 2026-03-18 | $485.00K derived: sum of 3 quarters · filed 2026-03-18 | $646.00K 10-K · filed 2026-03-18 |
| 2024-09-30 | $162.00K 10-Q · filed 2025-11-13 | $324.00K derived: sum of 2 quarters · filed 2025-11-13 | $485.00K 10-Q · filed 2025-11-13 | $643.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $162.00K 10-Q · filed 2025-08-06 | $323.00K 10-Q · filed 2025-08-06 | $481.00K derived: sum of 3 quarters · filed 2025-08-06 | $638.00K derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $162.00K 10-Q · filed 2025-05-07 | $319.00K derived: sum of 2 quarters · filed 2025-05-07 | $476.00K derived: sum of 3 quarters · filed 2025-05-07 | $633.00K derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | $157.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | $314.00K derived: sum of 2 quarters · filed 2025-03-19 | $471.00K derived: sum of 3 quarters · filed 2025-03-19 | $628.00K 10-K · filed 2025-03-19 |
| 2023-09-30 | $157.00K 10-Q · filed 2024-11-06 | $314.00K derived: sum of 2 quarters · filed 2024-11-06 | $471.00K 10-Q · filed 2024-11-06 | $627.00K derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $157.00K 10-Q · filed 2024-08-07 | $314.00K 10-Q · filed 2024-08-07 | $470.00K derived: sum of 3 quarters · filed 2024-08-07 | $621.00K derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $157.00K 10-Q · filed 2024-05-08 | $313.00K derived: sum of 2 quarters · filed 2024-05-08 | $464.00K derived: sum of 3 quarters · filed 2024-05-08 | $615.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $156.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $307.00K derived: sum of 2 quarters · filed 2024-03-20 | $458.00K derived: sum of 3 quarters · filed 2024-03-20 | $609.00K 10-K · filed 2024-03-20 |
| 2022-09-30 | $151.00K 10-Q · filed 2023-11-08 | $302.00K derived: sum of 2 quarters · filed 2023-11-08 | $453.00K 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $151.00K 10-Q · filed 2023-08-09 | $302.00K 10-Q · filed 2023-08-09 | ||
| 2022-03-31 | $151.00K 10-Q · filed 2023-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |